Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents

Gut

Volumn 53, Issue 1, 2004, Pages 85-90

  Alexakis, C ^a   Caruelle, J P ^a   Sezeur, A ^b   Cosnes, J ^c   Gendre, J P ^c   Mosnier, H ^b   Beaugerie, L ^c   Gallot, D ^d   Malafosse, M ^d   Barritault, D ^a   Kern, P ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b Hopital des Diaconesses   (France)

^c HÔPITAL ROTHSCHILD   (France)

^d BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; DEXTRAN DERIVATIVE; GLUCOCORTICOID; HEPARAN SULFATE; PEPSIN A; PROLINE; REGENERATING AGENT; RG 1192; RG 1503; TRITIUM; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; HUMAN TISSUE; INCUBATION TIME; INTESTINAL FIBROSIS; INTESTINE BIOPSY; ISOTOPE LABELING; MALE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; TISSUE REPAIR;

ADULT; AGED; COLLAGEN; COLLAGEN TYPE III; CROHN DISEASE; CULTURE TECHNIQUES; DEXTRANS; FEMALE; GLUCOCORTICOIDS; HUMANS; INTESTINES; MALE; MIDDLE AGED; OLIGOSACCHARIDES;

EID: 9144261202     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.53.1.85     Document Type: Article

References (35)

1. Becker JM. Surgical therapy for ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1999;2B:371-90.
2. Graham MF, Willey A, Adams J, et al. Corticosteroids increase procollagen gene expression, synthesis and secretion by human intestinal smooth muscle cells. Gastroenterology 1999;109:1454-61.
3. Pucilowska JB, Williams KL, Lund PK, et al. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am J Physiol Gastrointest Liver Physiol 2000;279:G653-9.
4. Alexander-Williams J. Traumatic perforation of the bowel. Injury 2000;21:294-5.
5. Alexander AC, Irving MH. Accumulation and pepsin solubility of collagens in the bowel of patients with Crohn's disease. Dis Colon Rectum 1990;33:956-62.
6. Graham MF, Diegelmann RF, Elson CO, et al. Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology 1988;94:257-65.
7. Lawrance IC, Maxwell L, Doe W. Inflammation location but not type, determines the increase in TGF beta1 and IGF1 expression and collagen deposition in IBD intestine. Inflamm Bowel Dis 2000;7:16-26.
8. Stallmach A, Schuppan D, Riese HH, et al. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Cronn's disease. Gastroenterology 1992;102:1920-9.
9. Powell DW, Mifflin RC, Valentich JD, et al. Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol Cell Physiol 1999;277:C183-201.
10. O'Kane S, Fergusson MWJ. Transforming growth factor betas and wound healing. Int J Biochem Cell Biol 1997;29:63-8.
11. Asselot-Chapel C, Combacau L, Labat-Robert J, et al. Expression of fibronectin and interstitial collagen genes in smooth muscle cells: modulation by low molecular weight heparin fragments and serum. Biochem Pharmacol 1995;49:653-9.
12. Aamiri A, Mobarek A, Carpentier G, et al. Effects of substituted dextran on reinnervation of a skeletal muscle in adult rats during regeneration. C R Acad Sci III 1995;318:1037-43.
13. Lafont J, Baroukh B, Berdal A, et al. RGTA11, a new healing agent, triggers developmental events during healing of craniotomy defects in adult rats. Growth Factors 1998;16:23-38.
14. Meddahi A, Blanquaert F, Saffar JL, et al. New approches to tissue regeneration and repair. Pathol Res Pract 1994;190:923-8.
15. Meddahi A, Benoit J, Ayoub N, et al. Heparin-like polymers derived from dextran enhance colonic anastomosis resistance to leakage. J Biomed Mater Res 1996;31:293-7.
16. Logeart D, Letourneur D, Jozefonvicz J, et al. Collagen synthesis by vascular smooth muscle cells in the presence of antiproliferative polysaccharides. J Biomed Mater Res 1996;30:501-8.
17. Benazzoug Y, Logeart D, Labat-Robert J, et al. Derivatized dextrans modulate collagen synthesis in aortic smooth muscle cells. Biochem Pharmacol 1995;49:847-53.
18. Mestries P, Borchiellini C, Barbaud C, et al. Chemically modified dextrans modulate expression of collagen phenotype by cultured smooth muscle cells in relation to the degree of carboxymethyl, benzylamide and sulfation substitutions. J Biomat Med Res 1998;42:286-94.
19. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6:8-15.
20. Choubet F, Champion J, Maiga O, et al. Synthesis and structure- anticoagulant property relationships of functionalized dextran. Carbohydr Polym 1995;28:145-52.
21. Ledoux D, Papy-Garcia D, Escartin Q, et al. Human plasmin enzymatic activity is inhibited by chemically modified dextrans. J Biol Chem 2000;275:29383-90.
22. Kern P, Menasche M, Robert L. Relative rates of biosynthesis of collagen type I, type V and type VI in calf cornea. Biochem J 1991;274:615-17.
23. El Nabout R, Martin M, Remy J, et al. Collagen synthesis and deposition in cultured fibroblasts from subcutaneous radiation-induced fibrosis. Modification as a function of cell aging. Matrix 1989;9:411-20.
24. Boyer B, Kern P, Fourtanier A, et al. Age dependent variations of the biosyntheses of fibronectin and fibrous collagens in mouse skin. Exp Gerontol 1988;26:375-83.
25. Sykes B, Puddle B, Francis M, et al. The estimation of two collagens from human dermes by interrupted gel electrophoresis. Biochem Biophys Res Com 1976;72:1472-80.
26. Meddahi A, Alexakis C, Papy-Garcia D, et al. Heparin-like polymer improved healing of gastric and colic ulceration. J Biomed Mater Res 2002;60:497-501.
27. Rubin E, Farber JL. Inflammatory bowel disease. In: Rubin E, Farber JL, eds. Pathology. Philadelphia: Lippincott JB, 1994:675-83.
28. von Lampe B, Barthel B, Coupland SE, et al. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 2000;47:63-73.
29. Shull S, Cutroneo KR. Glucocorticoids change the ratio of type III to type I procollagen extracellularly. Collagen Rel Res 1986;6:295-300.
30. Aurio P, Oikarinen A, Melkko J, et al. Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo, whereas isotretinoin treatment has no effect. Br J Dermatol 1994;131:660-3.
31. Anstead GM. Steroids, retinoids, and wound healing. Adv Wound Care 1998;11:277-85.
32. Mestries P, Alexakis C, Papy-Garcia D, et al. Specific RGTA increases collagen V expression by cultured aortic smooth muscle cells via activation and protection of transforming growth factor-beta 1. Matrix Biol 2000;20:171-81.
33. Alexakis C, Guettoufi A, Mestries P, et al. Heparan mimetic regulates collagen expression and TGF-betal distribution in gamma-irradiated human intestinal smooth muscle cells. FASEB J 2001;15:1546-54.
34. Majors A, Ehrhart LA. Basic fibroblast growth factor in the extracellular matrix suppresses collagen synthesis and type III procollagen mRNA levels in arterial smooth muscle cells cultures. Arterioscler Thromb 1993;13:680-6.
35. Senni K, Borchiellini C, Duchesnay A, et al. Antiproliferative polysaccharides modulate distribution and phenotypic expression of collagens by gingival fibroblasts. J Biomed Mater Res 1996;40:164-9.